BOSTON (MarketWatch) -- Drug stocks climbed in midday action Thursday as shares of Pharmion Corp., which had been hard hit in recent days, soared on positive data for its hematology drug Vidaza.
BOSTON (MarketWatch) -- Drug stocks climbed in midday action Thursday as shares of Pharmion Corp., which had been hard hit in recent days, soared on positive data for its hematology drug Vidaza.
